ATE460421T1 - Phosphinsäurederivate - Google Patents
PhosphinsäurederivateInfo
- Publication number
- ATE460421T1 ATE460421T1 AT04819605T AT04819605T ATE460421T1 AT E460421 T1 ATE460421 T1 AT E460421T1 AT 04819605 T AT04819605 T AT 04819605T AT 04819605 T AT04819605 T AT 04819605T AT E460421 T1 ATE460421 T1 AT E460421T1
- Authority
- AT
- Austria
- Prior art keywords
- acid derivatives
- phosphinic acid
- pharmaceuticals
- preparation
- pharmaceutical compositions
- Prior art date
Links
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical class O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0327186.3A GB0327186D0 (en) | 2003-11-21 | 2003-11-21 | Organic compounds |
| PCT/EP2004/013177 WO2005054259A1 (en) | 2003-11-21 | 2004-11-19 | Phosphinic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE460421T1 true ATE460421T1 (de) | 2010-03-15 |
Family
ID=29764265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04819605T ATE460421T1 (de) | 2003-11-21 | 2004-11-19 | Phosphinsäurederivate |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7498319B2 (de) |
| EP (1) | EP1687319B1 (de) |
| JP (1) | JP4478156B2 (de) |
| KR (1) | KR100807894B1 (de) |
| CN (1) | CN1882598B (de) |
| AT (1) | ATE460421T1 (de) |
| AU (1) | AU2004295060B2 (de) |
| BR (1) | BRPI0416226A (de) |
| CA (1) | CA2545589C (de) |
| DE (1) | DE602004025965D1 (de) |
| ES (1) | ES2341254T3 (de) |
| GB (1) | GB0327186D0 (de) |
| MX (1) | MXPA06005704A (de) |
| PL (1) | PL1687319T3 (de) |
| PT (1) | PT1687319E (de) |
| RU (1) | RU2368616C2 (de) |
| WO (1) | WO2005054259A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109125331A (zh) * | 2018-09-13 | 2019-01-04 | 大连医科大学附属第二医院 | Gabab受体拮抗剂在阻断trek-1通道方面的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8820266D0 (en) * | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
| IL98502A (en) | 1990-06-22 | 1998-04-05 | Ciba Geigy Ag | Aminoalkane phosphinic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| EP0767174A1 (de) * | 1991-11-21 | 1997-04-09 | Ciba-Geigy Ag | Neue Aminoalkanphosphinsäuren und ihre Salze |
| AU662404B2 (en) * | 1992-05-08 | 1995-08-31 | Novartis Ag | Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids |
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
-
2003
- 2003-11-21 GB GBGB0327186.3A patent/GB0327186D0/en not_active Ceased
-
2004
- 2004-11-19 AT AT04819605T patent/ATE460421T1/de active
- 2004-11-19 CN CN2004800343307A patent/CN1882598B/zh not_active Expired - Fee Related
- 2004-11-19 WO PCT/EP2004/013177 patent/WO2005054259A1/en not_active Ceased
- 2004-11-19 PL PL04819605T patent/PL1687319T3/pl unknown
- 2004-11-19 US US10/576,972 patent/US7498319B2/en not_active Expired - Fee Related
- 2004-11-19 KR KR1020067009807A patent/KR100807894B1/ko not_active Expired - Fee Related
- 2004-11-19 JP JP2006540346A patent/JP4478156B2/ja not_active Expired - Fee Related
- 2004-11-19 EP EP04819605A patent/EP1687319B1/de not_active Expired - Lifetime
- 2004-11-19 MX MXPA06005704A patent/MXPA06005704A/es active IP Right Grant
- 2004-11-19 PT PT04819605T patent/PT1687319E/pt unknown
- 2004-11-19 BR BRPI0416226-9A patent/BRPI0416226A/pt not_active IP Right Cessation
- 2004-11-19 CA CA2545589A patent/CA2545589C/en not_active Expired - Fee Related
- 2004-11-19 DE DE602004025965T patent/DE602004025965D1/de not_active Expired - Lifetime
- 2004-11-19 RU RU2006121648/04A patent/RU2368616C2/ru not_active IP Right Cessation
- 2004-11-19 AU AU2004295060A patent/AU2004295060B2/en not_active Ceased
- 2004-11-19 ES ES04819605T patent/ES2341254T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1687319B1 (de) | 2010-03-10 |
| GB0327186D0 (en) | 2003-12-24 |
| MXPA06005704A (es) | 2006-08-17 |
| CN1882598B (zh) | 2010-06-16 |
| US7498319B2 (en) | 2009-03-03 |
| EP1687319A1 (de) | 2006-08-09 |
| PT1687319E (pt) | 2010-06-04 |
| JP2007513088A (ja) | 2007-05-24 |
| KR20060097037A (ko) | 2006-09-13 |
| BRPI0416226A (pt) | 2007-01-02 |
| US20070259835A1 (en) | 2007-11-08 |
| RU2006121648A (ru) | 2008-01-10 |
| ES2341254T3 (es) | 2010-06-17 |
| JP4478156B2 (ja) | 2010-06-09 |
| AU2004295060B2 (en) | 2007-08-30 |
| RU2368616C2 (ru) | 2009-09-27 |
| CN1882598A (zh) | 2006-12-20 |
| PL1687319T3 (pl) | 2010-08-31 |
| WO2005054259A1 (en) | 2005-06-16 |
| DE602004025965D1 (en) | 2010-04-22 |
| CA2545589C (en) | 2013-03-12 |
| KR100807894B1 (ko) | 2008-02-27 |
| CA2545589A1 (en) | 2005-06-16 |
| AU2004295060A1 (en) | 2005-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0301653D0 (sv) | Novel compounds | |
| SE0301010D0 (sv) | Novel compounds | |
| SE0301700D0 (sv) | Novel compounds | |
| SE0301009D0 (sv) | Novel compounds | |
| NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
| ATE362932T1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
| SE0101675D0 (sv) | Novel composition | |
| TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| MXPA05012025A (es) | Imidazo y tiazolopiridinas como inhibidores de cinasa jak3. | |
| BRPI0408347B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
| CY1112721T1 (el) | Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| TW200732323A (en) | Organic compounds | |
| UA86591C2 (ru) | Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе | |
| PA8575601A1 (es) | Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
| NO20063062L (no) | Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse | |
| SE0302139D0 (sv) | Novel compounds | |
| DK1511489T3 (da) | Nye farmaceutiske sammensætninger indeholdende flibanserin-polymorf A | |
| EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
| TW200716568A (en) | 1H-quinazoline-2,4-diones | |
| MX2009000768A (es) | Lactamas macrociclicas. | |
| EA200702375A1 (ru) | Производные мочевины, способы их получения и применения | |
| SE0303280D0 (sv) | Novel compounds | |
| SE0300457D0 (sv) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1687319 Country of ref document: EP |